Innoviz Technologies Ltd (NASDAQ: INVZ): Hunting Genuine Value In Market Debris

Currently, there are 168.68M common shares owned by the public and among those 168.68M shares have been available to trade.

The company’s stock has a 5-day price change of 30.77% and 111.79% over the past three months. INVZ shares are trading -39.53% year to date (YTD), with the 12-month market performance down to -40.93% lower. It has a 12-month low price of $0.45 and touched a high of $2.82 over the same period. INVZ has an average intraday trading volume of 2.81 million shares. The stock is trading above its simple moving averages at the SMA20, SMA50, and SMA200, as the current price level is off by 76.13%, 107.88%, and 67.90% respectively.

3 Tiny Stocks Primed to Explode The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.

We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.

Click here for full details and to join for free
Sponsored

Institutional ownership of Innoviz Technologies Ltd (NASDAQ: INVZ) shares accounts for 32.11% of the company’s 168.68M shares outstanding.

It has a market capitalization of $282.66M and a beta (3y monthly) value of 0.98. The earnings-per-share (ttm) stands at -$0.64. Price movements for the stock have been influenced by the stock’s volatility, which stands at 23.09% over the week and 17.10% over the month.

Earnings per share for the fiscal year are expected to increase by 33.81%, and 7.55% over the next financial year.

Looking at the support for the INVZ, a number of firms have released research notes about the stock. Rosenblatt stated their Buy rating for the stock in a research note on December 20, 2024, with the firm’s price target at $4. Goldman was of a view on July 11, 2024 that the stock is Neutral, while Rosenblatt gave the stock Neutral rating on October 25, 2022, issuing a price target of $5. Berenberg on their part issued Buy rating on September 28, 2022.

Most Popular

Related Posts